Candel Therapeutics Stock

candeltx.comHealthcare / BioTech & PharmaFunding to Date: $67.6MM

Developer of cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Candel Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Candel Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Candel Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Stephen Rocamboli JD
Chief Business Officer
Laura Aguilar Ph.D
Chief Medical Officer
Estuardo Aguilar-Cordova Ph.D
Chief Executive Officer, Chairman and Co-Founder
Daniel Giroux
Vice President, Manufacturing
Brian Guzik Ph.D
Senior Director, Business Development

Board Members

Christopher Martell
Fred Mermelstein Ph.D
Michael Rubin MD
Northpond Ventures
Udi Meirav Ph.D
Edward Benz Jr.
Estuardo Aguilar-Cordova Ph.D
Glenn Mattes
Paul Manning
Alan Smith
Gregory Gailius
Mitchell Finer Ph.D
Sean Stalfort

Candel Therapeutics stock FAQs

plusminus

Can you buy Candel Therapeutics stock?

As Candel Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Candel Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Candel Therapeutics stock?

To invest in a private company like Candel Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Candel Therapeutics stock?

Yes, you may be able to sell your Candel Therapeutics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Candel Therapeutics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Candel Therapeutics stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Candel Therapeutics a public company?

No, Candel Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Candel Therapeutics’ stock price?

Candel Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Candel Therapeutics’ private market stock price with Forge Data.
plusminus

What is Candel Therapeutics’ stock ticker symbol?

Candel Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Advantagene, d.b.a. Candel Therapeutics, a company developing proprietary immuno-oncology platforms, closed a $22.5m Series C financing
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.